Pfizer Sues Cobalt Over Lipitor Patent
Pfizer Inc. is alleging that when Cobalt Pharmaceuticals Inc. filed an Abbreviated New Drug Application for a product whose active ingredient would be atorvastatin sodium, the Canadian generics outfit infringed a...To view the full article, register now.
Already a subscriber? Click here to view full article